Donor-Derived Viral Specific T-cells
Cell therapyexperimental
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
3
Phase 3
0
Phase 4
0
Earliest trial started Mar 16, 2019 (NCT03883906)
Timeline
2010s
- Jan 1, 2019
Earliest Phase 2 Sponsor(trial)
Indications
Mechanism of action
- UnclearImmunity, passive
Unclear immunity, passive
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04406064 | Phase 2 | Jun 30, 2020 | University of Cincinnati |
| NCT04331275 | Phase 2 | May 31, 2020 | University of Cincinnati |
| NCT03883906 | Phase 2 | Mar 16, 2019 | University of Cincinnati |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| University of Cincinnati | Academic/Hospital | 3 | 3 | 1 | 2019 |
1 organizations
Page 1 / 1